These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 16423393

  • 1. Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.
    Navarro I, Ruiz MA, Cabello A, Collado R, Ferrer R, Hueso J, Martinez J, Miguel A, Orero MT, Pérez P, Nolasco A, Carbonell F.
    Leuk Res; 2006 Aug; 30(8):971-7. PubMed ID: 16423393
    [Abstract] [Full Text] [Related]

  • 2. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
    Müller-Berndorff H, Haas PS, Kunzmann R, Schulte-Mönting J, Lübbert M.
    Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
    [Abstract] [Full Text] [Related]

  • 3. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
    Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R.
    Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
    [Abstract] [Full Text] [Related]

  • 4. Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes.
    Breccia M, Carmosino I, Biondo F, Mancini M, Russo E, Latagliata R, Alimena G.
    Leuk Res; 2006 Feb; 30(2):178-82. PubMed ID: 16102825
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course.
    Bacher U, Kern W, Alpermann T, Schnittger S, Haferlach C, Haferlach T.
    Leuk Res; 2012 Jul; 36(7):826-31. PubMed ID: 22554895
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Scoring analysis on prognosis of 63 patients with melodysplastic syndrome].
    Wei J, Chen Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):305-11. PubMed ID: 18426654
    [Abstract] [Full Text] [Related]

  • 11. Treatment of transfusional iron overload in patients with myelodysplastic syndrome or severe anemia: data from multicenter clinical practices.
    Raptis A, Duh MS, Wang ST, Dial E, Fanourgiakis I, Fortner B, Paley C, Mody-Patel N, Corral M, Scott J.
    Transfusion; 2010 Jan; 50(1):190-9. PubMed ID: 19719471
    [Abstract] [Full Text] [Related]

  • 12. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH, Xu ZF, Li L, Nie L, Liu L, Zhang Y, Qin TJ, Hao YS, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [Abstract] [Full Text] [Related]

  • 13. [Karyotypic and IPSS grouping of primary myelodysplastic syndromes patients: a comparison between FAB- and WHO-classification].
    Yu MH, Liu SH, Shao YQ, Hao YS, Xiao ZJ.
    Zhonghua Xue Ye Xue Za Zhi; 2004 Aug; 25(8):482-5. PubMed ID: 15555265
    [Abstract] [Full Text] [Related]

  • 14. Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome.
    Lee JH, Lee JH, Shin YR, Lee JS, Kim WK, Chi HS, Park CJ, Seo EJ, Lee KH.
    Leukemia; 2003 Feb; 17(2):305-13. PubMed ID: 12592327
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow blasts level predicts prognosis in patients with refractory cytopenia with multilineage dysplasia.
    Wang H, Wang XQ, Xu XP, Lin GW.
    Eur J Haematol; 2009 Dec 01; 83(6):550-8. PubMed ID: 19737310
    [Abstract] [Full Text] [Related]

  • 16. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
    Rubio-Félix D, Giraldo MP, Perella M, Gimeno J, Franco E, Giralt M.
    Sangre (Barc); 1991 Dec 01; 36(6):463-9. PubMed ID: 1812580
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.
    Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, Travaglino E, Passamonti F, Arcaini L, Maffioli M, Bernasconi P, Lazzarino M, Cazzola M.
    J Clin Oncol; 2005 Oct 20; 23(30):7594-603. PubMed ID: 16186598
    [Abstract] [Full Text] [Related]

  • 18. [The application of a new prognostic score system for 435 cases of primary myelodysplastic syndrome diagnosed with WHO classification].
    Wang XQ, Sino-US Leukemia Cooperative Group of Shanghai.
    Zhonghua Nei Ke Za Zhi; 2009 Aug 20; 48(8):633-7. PubMed ID: 19954053
    [Abstract] [Full Text] [Related]

  • 19. A comparative review of classification systems in myelodysplastic syndromes (MDS).
    Bennett JM.
    Semin Oncol; 2005 Aug 20; 32(4 Suppl 5):S3-10. PubMed ID: 16085011
    [Abstract] [Full Text] [Related]

  • 20. [Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients].
    Dewulf G, Gouin I, Pautas E, Gaussem P, Chaïbi P, Andreux JP, Siguret V.
    Ann Biol Clin (Paris); 2004 Aug 20; 62(2):197-202. PubMed ID: 15047472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.